Effect of different pharmacological formulations of gliclazide on postprandial hyperglycaemia

Diabet Med. 1998 Aug;15(8):706. doi: 10.1002/(SICI)1096-9136(199808)15:8<706::AID-DIA654>3.0.CO;2-6.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial
  • Letter

MeSH terms

  • Blood Glucose / metabolism
  • Chemistry, Pharmaceutical
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Female
  • Gliclazide / chemistry
  • Gliclazide / therapeutic use*
  • Humans
  • Hyperglycemia / drug therapy*
  • Hyperglycemia / etiology
  • Hypoglycemic Agents / chemistry
  • Hypoglycemic Agents / therapeutic use*
  • Male
  • Postprandial Period

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Gliclazide